Cephalon Announces Agreement to Acquire AMRIX, a Once-Daily Extended-Release Muscle Relaxant

Cephalon announced it has signed an agreement to acquire the North American rights to Amrix (cyclobenzaprine hydrochloride extended-release capsules) from ECR Pharmaceuticals, a privately held company.
Cephalon